Literature DB >> 7552516

Quantification of the variation due to laboratory and physiologic sources in CD4 lymphocyte counts of clinically stable HIV-infected individuals.

J M Raboud1, L Haley, J S Montaner, C Murphy, M Januszewska, M T Schechter.   

Abstract

We have conducted a study to quantify the amount of variation in the CD4 lymphocyte counts of HIV-infected individuals due to laboratory and physiological factors. Thirty HIV-infected male volunteers had blood drawn on six occasions: three times in each of 2 weeks, 4 weeks apart. Two tubes of blood were drawn at each visit, and duplicate measurements were obtained from one of the tubes of blood. Differences between duplicate measurements from a single tube of blood and between CD4 counts obtained from two tubes of blood drawn on the same day were attributed to laboratory factors. Differences between CD4 counts obtained on different days were attributed to a combination of laboratory factors and physiologic factors, which included the effects of exercise, tobacco, and the consumption of alcohol and caffeine. The mean absolute CD4 count at the first visit was 450 (range 86-1,081). The short-term coefficient of variation of CD4 count was 13.7 (95% CI: 12.9, 14.6). Physiologic and laboratory factors accounted for 85% and 15% of the variation in CD4 counts, respectively. Variation in the absolute white blood cell count, lymphocyte percentage, and CD4 percentage accounted fo 52%, 29%, and 19% of the physiologic variation in CD4 counts, respectively. Our results confirm a high degree of short-term variability of CD4 counts among HIV-infected individuals, which can be largely attributed to physiological factors. This variability can be minimized more effectively by repeating CD4 counts over time than by repeating measurements at a single visit.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7552516

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  27 in total

1.  HIV and aerobic exercise. Current recommendations.

Authors:  W W Stringer
Journal:  Sports Med       Date:  1999-12       Impact factor: 11.136

2.  Nevirapine pharmacokinetics and risk of rash and hepatitis among HIV-infected sub-Saharan African women.

Authors:  Betty J Dong; Yu Zheng; Michael D Hughes; Adam Frymoyer; Davide Verotta; Patricia Lizak; Frederick Sawe; Judith S Currier; Shahin Lockman; Francesca T Aweeka
Journal:  AIDS       Date:  2012-04-24       Impact factor: 4.177

3.  The Relationship Between Caffeine Intake and Immunological and Virological Markers of HIV Disease Progression in Miami Adult Studies on HIV Cohort.

Authors:  Venkataraghavan Ramamoorthy; Adriana Campa; Muni Rubens; Sabrina S Martinez; Christina Fleetwood; Tiffanie Stewart; Juan P Liuzzi; Florence George; Hafiz Khan; Yinghui Li; Marianna K Baum
Journal:  Viral Immunol       Date:  2017-04-14       Impact factor: 2.257

4.  The Italian quality control study for evaluation of CD4 cells in centres involved in the treatment of HIV-1 patients. Italian CD4 Quality Control Group.

Authors:  F Pandolfi; C Alario; E Girardi; L Rava; G Ippolito; A Kunkl; F Aiuti
Journal:  Clin Exp Immunol       Date:  1998-03       Impact factor: 4.330

5.  CD4 measurement in a 54-year-old man with sustained HIV-1 viral suppression.

Authors:  Allan Yan; Jerome A Leis; Wayne L Gold
Journal:  CMAJ       Date:  2016-03-29       Impact factor: 8.262

6.  CD4 Count in HIV- Brain-Dead Donors: Insight into Donor Risk Assessment for HIV+ Donors.

Authors:  Oscar Kenneth Serrano; Scott Kerwin; William D Payne; Timothy L Pruett
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

7.  Is frequent CD4+ T-lymphocyte count monitoring necessary for persons with counts >=300 cells/μL and HIV-1 suppression?

Authors:  Howard B Gale; Steven R Gitterman; Heather J Hoffman; Fred M Gordin; Debra A Benator; Ann M Labriola; Virginia L Kan
Journal:  Clin Infect Dis       Date:  2013-01-11       Impact factor: 9.079

8.  Simultaneous Treatment of Missing Data and Measurement Error in HIV Research Using Multiple Overimputation.

Authors:  Michael Schomaker; Sara Hogger; Leigh F Johnson; Christopher J Hoffmann; Till Bärnighausen; Christian Heumann
Journal:  Epidemiology       Date:  2015-09       Impact factor: 4.822

9.  Immunological effect of aqueous extract of Vernonia amygdalina and a known immune booster called immunace(®) and their admixtures on HIV/AIDS clients: a comparative study.

Authors:  M A Momoh; U Muhamed; A A Agboke; E I Akpabio; Uduma Eke Osonwa
Journal:  Asian Pac J Trop Biomed       Date:  2012-03

10.  Errors in 'BED'-derived estimates of HIV incidence will vary by place, time and age.

Authors:  Timothy B Hallett; Peter Ghys; Till Bärnighausen; Ping Yan; Geoff P Garnett
Journal:  PLoS One       Date:  2009-05-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.